Myocardial Infarction Mortality Risk after Treatment for HL: a Collaborative British Cohort Study
Anthony Swerdlow
Risk Factors for Cardiovascular Disease; Dutch Results
Berthe Aleman
Clinical Applications of Modelled Second Cancer Risk Among HL Survivors
David Hodgson
Breast Tumors Induced by High-dose Radiation Display Similar Genetic Profiles
Annegien Broeks
Screening for Lung Cancer in Patients at High Risk of this Second Cancer after Treatment for HL
John Radford
Breast Cancer Screening with MRI in Female HL Survivors
Andrea Ng
14:00 – 15:30
Room: Pipin I
(Dorint Hotel)
WorkshopPathology
Randy Gascoyne
Harald Stein
Cytokine Gene Expression and T-Cell Transcription Factor Profile of the T-Cells of the Nodular Lymphocyte Predominance Type of HL
Cigdem Atayar
Double-Positive CD4+CD8+ T-Cell Populations in Nodular Lymphocyte Predominant HL: Further Characterization and Relationship to Other Entities
Aliyah Rahemtullah
CD4/CD8-double Positive T-Cells in Nodular Lymphocyte Predominance HL
Randy Gascoyne
Regulatory T-Cells in Classical HL
Ramon Bosch
Biologic Prognostic Markers in cHL: Evaluation of Characteristics of RS Cells as well as the Tumor Infiltrating Lymphocytes
Eric Hsi
dentification and Purification of Hodgkin Cells from Lymph Nodes Involved by Classical HL by Flow Cytometry and Flow Cytometric Cell Sorting
Jonathan Fromm
14:00 – 15:30
Room: Martin & Augustin
(Dorint Hotel)
WorkshopAllogeneic Stem Cell Transplantation
James Armitage
Norbert Schmitz
Allogeneic Hematopoietic Cell Transplantation for HL
Ginna Laport
Allogeneic Stem Cell Transplantation (Allo-SCT) in HL: The European Point of View
Anna Sureda
Improved Outcome Following Reduced Intensity Allogeneic Transplantation in HL Relapsing Post-Autologous Transplantation
Stephen Mackinnon
Allogeneic/Syngeneic/Autologous Transplantation – a Comparison
Philip Bierman
14:00 – 15:30
Room: Severin
(Dorint Hotel)
WorkshopPædiatric Hodgkin Lymphoma
Dieter Körholz
Judith Landman-Parker
Current Protocols and Concepts in the USA
Cindy L. Schwartz
Strategy of the EuroNet-PHL-C1 Protocol for the Treatment of Classical HL in Children and Adolescents
Dieter Körholz
First International Inter-Group Study for Lymphocyte Predominant HL in Children and Adolescents
Judith Landman-Parker
Current Children’s Oncology Group (COG) Protocol for LPHL
Burton Appel
16:00 – 17:30
Room: Pipin II
(Dorint Hotel)
WorkshopFuture Studies / Intergroup Trials
Richard Fisher
John Raemaekers
The new trial generation of the German Hodgkin Study Group (GHSG)
Andreas Engert
The H10 EORTC/GELA Randomized Intergroup Trial on Early FDG-PET Scan Guided Treatment Adaptation Versus Standard Combined Modality Treatment in Patients with Supradiaphragmatic Stage I/II HL
Marc André
Response-Adapted Therapy Using FDG-PET Scanning after Initial ABVD: The UK NCRI, Italian and Nordic Trial in Advanced HL
Peter Johnson
Identification of Relevant and Practical Questions for an Transatlantic Intergroup Designs
Oliver Press
Development of ABVD as Standard Treatment for HL
Bruce Cheson
Organisation Central On-line PET Review
Sigrid Stroobants
16:00 – 18:00
Room: Isabellensaal
Scientific SessionChronic Inflammation
Bernd Dörken
Sibrand Poppema
RNA Expression Analyses of whole Tissue Sections
Juan Fernando Garcia Garcia
The Role of Inflammatory Bystander Cells in HL
Gunilla Enblad
Gene Expression Profiling in HL: the RS Cells or the Microenvironment?
Christian Steidl
Elevated levels of HLA-B associated transcript 3 (BAT3) in sera from Hodgkin Lymphoma patients
Elke Pogge von Strandmann
T-Cells in HL
Sibrand Poppema
Autoimmunity and HL
Ola Landgren
The EBV-encoded EBNA1 in HL Cells Mediates Upregulation of the Chemokine CCL20 and the Migration of Regulatory T-Cells
Karl R. N. Baumforth
Aberrant Notch1 Activity Contributes to Plasticity of HRS Cells